The Sentinel GroupThe Sentinel Group Facebook ad: “Dupixent Lawsuit Review”
Ran for 12 days, from March 31 to April 12, 2026, the last day Crush saw it.
Run by The Sentinel Group on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 2159828968103535
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 0
Ad text
Have you or a loved one been diagnosed with CTCL or a T-cell lymphoma after using Dupixent? Some reports are exploring a potential link between dupilumab and certain lymphoma diagnoses. If you experienced new or worsening symptoms after treatment, you may be eligible to have your case reviewed. Submit your details for a confidential, no-obligation case evaluation.
Where the ad sends people
tsgtort.com
Dupixent Lawsuit Review
Check if you may qualify
Learn more: tsgtort.com(opens in a new tab)
